REGENIN S Professional Sculpting Ampoule

Innovative Lipolysis with Next‑Generation Peptide

This localized contouring ampoule, developed specifically for aesthetic medicine and professional body sculpting treatments, features the exclusive next-generation peptide Regentide as its core. It effectively targets fat cell signals, selectively initiating lipolysis without harming surrounding skin tissues, making it suitable for treating double chins, localized body fat, and cellulite.

Research and Clinical Highlights
REGENIN S utilizes the brand's self-developed next-generation lipolytic peptide, Regentide, which specifically targets fat cells to initiate lipolysis. It only reduces the volume of fat cells without damaging surrounding skin tissues, thereby minimizing the risk of skin laxity. Clinical data shows a significant reduction in submental fat volume and protrusion within just 8 weeks, alongside an improvement in thigh cellulite and rough skin texture, achieving contouring while maintaining skin tightness and smoothness.

Key Efficacy Highlights

🔸 Precisely targets fat cells with exclusive lipolytic peptide Regentide, initiating selective lipolysis.

🔸 Reduces only fat cell volume without damaging surrounding skin structures, maintaining firmness and elasticity, and reducing the risk of sagging.

🔸 Addresses localized fat and cellulite issues in areas such as double chin, arms, waist flanks, and hips/thighs, improving contours and unevenness.

🔸 Strong percutaneous absorption, suitable for topical application with device introduction. Clinical data also supports its application via injection.

🔸 Clinically proven: Significantly reduces submental fat volume and protrusion within 8 weeks, while also improving thigh cellulite and skin roughness.

🔸 Precise lipolysis: Initiates lipolysis through a fat-cell-specific signaling pathway, rather than mere edema metabolism, reducing concerns about "pseudo-weight loss."

🔸 Skin structure friendly: Reduces fat cells while preserving dermal and supporting tissues, resulting in tighter contours and less sagging.

🔸 Peptide platform background: Developed by NineBiopharm, a company dedicated to peptide development, with a complete peptide research, development, and commercialization chain.

🔸 Multiple clinical supports: Includes clinical imaging and objective measurement data for double chin, thighs, and various body parts.

5.5cc x 5 vials

Price upon request